GPX4 and lung cancer: Ginkgetin was found to decrease the GPX4 protein levels and inhibit the antioxidant defense system of cells to cause ferroptosis in melanoma cells, whereas nobiletin reversed cisplatin resistance and increased lipid peroxidation and LIP levels in lung cancer cells [101, 102].